Cha B, Bang BW, Shin JB, Ko EJ, et al. Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area. Scand J Gastroenterol 2021 Aug 8:1-6. doi: 10.1080/00365521.2021.1948606.
PMID: 34369255